Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2V1 pseudogene 6 (UBE2V1P6) is a non-functional genomic sequence related to the active ubiquitin-conjugating enzyme E2 variant 1 gene (UBE2V1). Unlike its protein-coding counterpart, UBE2V1P6 does not encode a functional enzyme, receptor, or protein and has no known biological activity, disease association, or utility as a drug target. Its presence is a reflection of gene duplication and evolutionary events and does not contribute to cellular function or pathology[1][3]. Most functional information available for **UBE2V1** concerns the protein-coding gene, not the pseudogene. UBE2V1 is involved in K63-linked protein ubiquitination and may play a role in disease processes, but UBE2V1P6 does not share these functions[1][3][5]. When structuring information for databases, UBE2V1P6 should be classified as a **non-functional pseudogene** with no relevant therapeutic, biomarker, drug, or mechanistic data. Queries regarding its function or role as a therapeutic target are inappropriate except in rare and specialized research contexts.
None. Drug mechanisms of action do not apply to a pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UBE2V1 pseudogene 6 (UBE2V1P6).